drugset / Trial / NCT05593588
Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if the supplement, Fisetin, can be used as a treatment option for common variable immunodeficiency (CVID) by comparing its efficacy to placebo.
Timeline
- Start
- 2023-04-12
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fisetin | Small molecule | 20 mg/kg | Oral |